In: Integrative Physiological and Behavioral Science, 1998, vol. 33, no. 4, p. 344-362
|
In: Integrative Physiological and Behavioral Science, 1998, vol. 33, no. 1, p. 9-40
|
In: Proceedings of the International Astronomical Union, 2013, vol. 8, no. S299, p. 17-20
|
In: Monthly Notices of the Royal Astronomical Society, 2012, vol. 423, no. 4, p. 3679-3691
|
In: British Journal of Anaesthesia, 2004, vol. 92, no. 5, p. 641-650
|
In: Neuropathology and Applied Neurobiology, 2008, vol. 34, no. 4, p. 435 - 445
Aims: Prion diseases are generally characterized by pronounced neuronal loss. In particular, a subpopulation of inhibitory neurones, characterized by the expression of the calcium-binding protein parvalbumin (PV), is selectively destroyed early in the course of human and experimental prion diseases. By contrast, nerve cells expressing calbindin D28k (CB), another calcium-binding protein, as well...
|